|
CN107648668B
(zh)
|
2010-10-06 |
2021-06-18 |
哈佛学院董事会 |
用于基于材料的细胞疗法的可注射的成孔水凝胶
|
|
AU2013271375B2
(en)
|
2012-06-08 |
2018-03-22 |
Aduro Biotech, Inc. |
Compositions and methods for cancer immunotherapy
|
|
AU2013358892B2
(en)
|
2012-12-13 |
2018-06-21 |
Aduro Biotech, Inc. |
Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use
|
|
KR102255996B1
(ko)
|
2012-12-19 |
2021-05-26 |
보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 |
포유동물 시클릭 디-뉴클레오티드 신호 경로의 약학적 표적화
|
|
JP2016524593A
(ja)
|
2013-04-29 |
2016-08-18 |
メモリアル スローン−ケタリング キャンサー センター |
セカンドメッセンジャーのシグナル伝達を変えるための組成物及び方法
|
|
ES2822584T3
(es)
*
|
2013-05-03 |
2021-05-04 |
Univ California |
Inducción de dinucleótidos cíclicos del interferón tipo I
|
|
WO2014189806A1
(en)
*
|
2013-05-18 |
2014-11-27 |
Aduro Biotech, Inc. |
Compositions and methods for inhibiting "stimulator of interferon gene" dependent signalling
|
|
US9549944B2
(en)
|
2013-05-18 |
2017-01-24 |
Aduro Biotech, Inc. |
Compositions and methods for inhibiting “stimulator of interferon gene”—dependent signalling
|
|
PE20160080A1
(es)
|
2013-05-18 |
2016-02-21 |
Aduro Biotech Inc |
Composiciones y metodos para activar la senalizacion que depende del estimulador del gen de interferon
|
|
WO2015017652A1
(en)
|
2013-07-31 |
2015-02-05 |
Memorial Sloan-Kettering Cancer Center |
Sting crystals and modulators
|
|
EP3071209A4
(en)
*
|
2013-11-19 |
2017-08-16 |
The University of Chicago |
Use of sting agonist as cancer treatment
|
|
CN103908468B
(zh)
*
|
2014-04-21 |
2017-02-08 |
上海捌加壹医药科技有限公司 |
环二核苷酸cGAMP在制备抗肿瘤药物中的应用
|
|
US10682400B2
(en)
|
2014-04-30 |
2020-06-16 |
President And Fellows Of Harvard College |
Combination vaccine devices and methods of killing cancer cells
|
|
JP6462006B2
(ja)
|
2014-06-04 |
2019-01-30 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ |
Ｓｔｉｎｇのモジュレーターとしての環式ジヌクレオチド
|
|
US11058758B2
(en)
|
2014-11-20 |
2021-07-13 |
National Institutes Of Biomedical Innovation, Health And Nutrition |
TH1-inducing adjuvant comprising combination of different nucleic acid adjuvants, and use of same
|
|
CN107148424B
(zh)
|
2014-12-16 |
2021-01-08 |
凯拉治疗股份公司 |
用于诱导细胞因子的环状二核苷酸
|
|
GB201501462D0
(en)
|
2015-01-29 |
2015-03-18 |
Glaxosmithkline Ip Dev Ltd |
Novel compounds
|
|
WO2016130616A1
(en)
|
2015-02-11 |
2016-08-18 |
The Johns Hopkins University |
Bacteria over-expressing c-di-amp and therapeutic methods
|
|
US10449211B2
(en)
*
|
2015-03-10 |
2019-10-22 |
Aduro Biotech, Inc. |
Compositions and methods for activating “stimulator of interferon gene”—dependent signalling
|
|
CA2988086C
(en)
|
2015-06-03 |
2023-09-19 |
The Medical College Of Wisconsin, Inc. |
An engineered ccl20 locked dimer polypeptide
|
|
US11571462B2
(en)
|
2015-06-03 |
2023-02-07 |
The Medical College Of Wisconsin, Inc. |
Engineered CCL20 locked dimer polypeptide
|
|
EA034786B1
(ru)
|
2015-08-13 |
2020-03-20 |
Мерк Шарп И Доум Корп. |
Циклические динуклеотидные соединения в качестве агонистов sting
|
|
US11453697B1
(en)
|
2015-08-13 |
2022-09-27 |
Merck Sharp & Dohme Llc |
Cyclic di-nucleotide compounds as sting agonists
|
|
HK1257840A1
(zh)
|
2015-09-01 |
2019-11-01 |
Agenus Inc. |
抗-pd-1抗体及其使用方法
|
|
CN105367617A
(zh)
*
|
2015-09-25 |
2016-03-02 |
武汉品生科技有限公司 |
一种基于环二腺核苷酸的衍生物、tat多肽及其在一型干扰素小分子中抑制剂的应用
|
|
EP3368072A4
(en)
*
|
2015-10-28 |
2019-07-03 |
Aduro BioTech, Inc. |
COMPOSITIONS AND METHOD FOR ACTIVATING SIGNALING DEPENDENT ON THE STIMULATOR OF THE INTERFERON GENE
|
|
CN106539813B
(zh)
*
|
2015-11-30 |
2019-12-03 |
杭州星鳌生物科技有限公司 |
干扰素刺激基因(sting)激活剂在抗炎症中的应用
|
|
RU2020113165A
(ru)
*
|
2015-12-03 |
2020-06-09 |
Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед |
Циклические пуриновые динуклеотиды в качестве модуляторов sting
|
|
CN106539814A
(zh)
*
|
2015-12-09 |
2017-03-29 |
聊城市奥润生物医药科技有限公司 |
干扰素基因刺激蛋白（sting）激动剂在抗类风湿性关节炎等疾病中的应用
|
|
CN106540260A
(zh)
*
|
2015-12-09 |
2017-03-29 |
聊城市奥润生物医药科技有限公司 |
干扰素基因刺激蛋白（sting）激动剂在抗阿尔兹海默症中的应用
|
|
CN106554416B
(zh)
*
|
2015-12-09 |
2019-03-15 |
聊城市奥润生物医药科技有限公司 |
一种抗pd-l1人源化单克隆抗体联合干扰素基因刺激蛋白（sting）激动剂在抗肿瘤中的应用
|
|
US20180369268A1
(en)
*
|
2015-12-16 |
2018-12-27 |
Aduro Biotech, Inc. |
Methods for identifying inhibitors of "stimulator of interferon gene"- dependent interferon production
|
|
CN108601731A
(zh)
|
2015-12-16 |
2018-09-28 |
磨石肿瘤生物技术公司 |
新抗原的鉴别、制造及使用
|
|
SMT202500412T1
(it)
|
2016-01-11 |
2025-11-10 |
Innate Tumor Immunity Inc |
Dinucleotidi ciclici per il trattamento di condizioni associate all’attività di sting quali il cancro
|
|
AU2017225769B2
(en)
*
|
2016-03-02 |
2023-01-05 |
The Board Of Regents Of The University Of Texas System |
Sting activating nanovaccine for immunotherapy
|
|
NZ746112A
(en)
|
2016-03-18 |
2023-01-27 |
Immune Sensor Llc |
Cyclic di-nucleotide compounds and methods of use
|
|
CN106539757A
(zh)
*
|
2016-03-20 |
2017-03-29 |
聊城市奥润生物医药科技有限公司 |
环二核苷酸cGAMP-脂质体在抗肿瘤中的应用
|
|
JP2019510802A
(ja)
|
2016-04-07 |
2019-04-18 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ |
タンパク質調節物質として有用な複素環アミド
|
|
CN113549110B
(zh)
|
2016-04-07 |
2024-08-16 |
葛兰素史密斯克莱知识产权发展有限公司 |
用作蛋白质调节剂的杂环酰胺
|
|
WO2017186711A1
(en)
|
2016-04-25 |
2017-11-02 |
Invivogen |
Novel complexes of immunostimulatory compounds, and uses thereof
|
|
US10696985B1
(en)
|
2016-06-06 |
2020-06-30 |
Vanderbilt University |
Reversibly crosslinked endosomolytic polymer vesicles for cytosolic drug delivery
|
|
US11098077B2
(en)
|
2016-07-05 |
2021-08-24 |
Chinook Therapeutics, Inc. |
Locked nucleic acid cyclic dinucleotide compounds and uses thereof
|
|
AU2017293781B2
(en)
*
|
2016-07-06 |
2022-12-22 |
Invox Pharma Limited |
Compounds, compositions, and methods for the treatment of disease
|
|
WO2018013924A1
(en)
|
2016-07-15 |
2018-01-18 |
Massachusetts Institute Of Technology |
Synthetic nanoparticles for delivery of immunomodulatory compounds
|
|
DE102016113714A1
(de)
|
2016-07-26 |
2018-02-01 |
Rosa Karl |
Transfektionsverfahren mit nicht-viralen Genliefersystemen
|
|
NL2017267B1
(en)
|
2016-07-29 |
2018-02-01 |
Aduro Biotech Holdings Europe B V |
Anti-pd-1 antibodies
|
|
NL2017270B1
(en)
|
2016-08-02 |
2018-02-09 |
Aduro Biotech Holdings Europe B V |
New anti-hCTLA-4 antibodies
|
|
EP3493842A4
(en)
|
2016-08-02 |
2020-07-29 |
President and Fellows of Harvard College |
BIOMATERIALS TO MODULATE IMMUNE RESPONSES
|
|
KR102497742B1
(ko)
|
2016-08-30 |
2023-02-10 |
다나-파버 캔서 인스티튜트 인크. |
약물 전달 조성물 및 그의 용도
|
|
WO2018053508A1
(en)
*
|
2016-09-19 |
2018-03-22 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for inducing an immune response
|
|
US10537590B2
(en)
|
2016-09-30 |
2020-01-21 |
Boehringer Ingelheim International Gmbh |
Cyclic dinucleotide compounds
|
|
TN2020000158A1
(en)
|
2016-10-04 |
2022-04-04 |
Merck Sharp & Dohme |
BENZO[b]THIOPHENE COMPOUNDS AS STING AGONISTS
|
|
US10266558B2
(en)
*
|
2016-10-07 |
2019-04-23 |
Alexandre Vasilievich Ivachtchenko |
Macroheterocyclic nucleoside derivatives and their analogues, production and use thereof
|
|
EP3523314A1
(de)
|
2016-10-07 |
2019-08-14 |
Biolog Life Science Institute Forschungslabor Und Biochemica-Vertrieb GmbH |
Benzimidazolhaltige cyclische dinukleotide, verfahren zu deren herstellung und ihre verwendung zur aktivierung von stimulator von interferongenen (sting)-abhängigen signalwegen
|
|
JOP20170192A1
(ar)
|
2016-12-01 |
2019-01-30 |
Takeda Pharmaceuticals Co |
داي نوكليوتيد حلقي
|
|
EP3551225A1
(en)
|
2016-12-07 |
2019-10-16 |
Agenus Inc. |
Antibodies and methods of use thereof
|
|
WO2018119117A1
(en)
*
|
2016-12-22 |
2018-06-28 |
The Regents Of The University Of California |
Methods of producing cyclic dinucleotides
|
|
JP2018131427A
(ja)
*
|
2017-02-17 |
2018-08-23 |
国立研究開発法人理化学研究所 |
免疫細胞の制御技術
|
|
US20200055883A1
(en)
|
2017-02-17 |
2020-02-20 |
Eisai R&D Management Co., Ltd. |
Cyclic di-nucleotides derivative for the treatment of cancer
|
|
EP3585379A4
(en)
|
2017-02-21 |
2020-12-02 |
Board of Regents, The University of Texas System |
CYCLIC DINUCLEOTIDES USED AS AGONISTS OF THE INTERFERON-DEPENDENT SIGNALING STIMULATOR
|
|
CN106928298B
(zh)
*
|
2017-03-13 |
2021-10-22 |
杭州星鳌生物科技有限公司 |
环二核苷酸cGAMP衍生物的结构组成、制备方法及其在抗肿瘤中的应用
|
|
JOP20190218A1
(ar)
*
|
2017-03-22 |
2019-09-22 |
Boehringer Ingelheim Int |
مركبات ثنائية النيوكليوتيدات حلقية معدلة
|
|
SG11201908813QA
(en)
|
2017-04-13 |
2019-10-30 |
Aduro Biotech Holdings Europe B V |
Anti-sirp alpha antibodies
|
|
AU2018252193B2
(en)
|
2017-04-14 |
2024-12-12 |
Tallac Therapeutics, Inc. |
Immunomodulating polynucleotides, antibody conjugates thereof, and methods of their use
|
|
AR113224A1
(es)
|
2017-04-28 |
2020-02-19 |
Novartis Ag |
Conjugados de anticuerpo que comprenden un agonista de sting
|
|
UY37695A
(es)
|
2017-04-28 |
2018-11-30 |
Novartis Ag |
Compuesto dinucleótido cíclico bis 2’-5’-rr-(3’f-a)(3’f-a) y usos del mismo
|
|
EP3621624B1
(en)
|
2017-05-12 |
2023-08-30 |
Merck Sharp & Dohme LLC |
Cyclic di-nucleotide compounds as sting agonists
|
|
WO2018232217A1
(en)
|
2017-06-16 |
2018-12-20 |
William Marsh Rice University |
Hydrogel delivery of sting immunotherapy for treatment of cancer
|
|
US11285131B2
(en)
|
2017-08-04 |
2022-03-29 |
Merck Sharp & Dohme Corp. |
Benzo[b]thiophene STING agonists for cancer treatment
|
|
RU2020109328A
(ru)
|
2017-08-04 |
2021-09-06 |
Мерк Шарп И Доум Корп. |
Комбинации антагонистов pd-1 и бензо[b]тиофеновых агонистов sting для лечения рака
|
|
CN111263767B
(zh)
|
2017-08-30 |
2023-07-18 |
北京轩义医药科技有限公司 |
作为干扰素基因调节剂的刺激剂的环状二核苷酸
|
|
CA3074232A1
(en)
|
2017-08-31 |
2019-03-07 |
Sperovie Biosciences, Inc. |
Compounds, compositions, and methods for the treatment of disease
|
|
US11707531B2
(en)
|
2017-09-11 |
2023-07-25 |
F-star Therapeutics, Inc. |
Compounds, compositions, and methods for the treatment of disease
|
|
WO2019051488A1
(en)
|
2017-09-11 |
2019-03-14 |
Sperovie Biosciences, Inc. |
COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISEASE
|
|
JP7654240B2
(ja)
|
2017-09-19 |
2025-04-01 |
マサチューセッツ インスティテュート オブ テクノロジー |
キメラ抗原受容体ｔ細胞治療のための組成物およびその使用
|
|
JP2020536106A
(ja)
|
2017-10-05 |
2020-12-10 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ |
Ｈｉｖの処置に有用なインターフェロン遺伝子の刺激物質（ｓｔｉｎｇ）の調節物質
|
|
BR112020006780A2
(pt)
|
2017-10-05 |
2020-10-06 |
Glaxosmithkline Intellectual Property Development Limited |
moduladores do estimulador de genes do interferon (sting)
|
|
EP4576103A3
(en)
|
2017-10-10 |
2025-08-27 |
Gritstone bio, Inc. |
Neoantigen identification using hotspots
|
|
CN111566119A
(zh)
|
2017-11-10 |
2020-08-21 |
武田药品工业有限公司 |
Sting调节剂化合物以及制备和使用方法
|
|
US11673891B2
(en)
|
2017-11-14 |
2023-06-13 |
Dana-Farber Cancer Institute, Inc. |
Imidazopyrimidine compounds and uses thereof
|
|
JP7382316B2
(ja)
*
|
2017-11-14 |
2023-11-16 |
ザ チルドレンズ メディカル センター コーポレーション |
ヒト免疫応答をモジュレートするためのイミダゾピリミジンの使用
|
|
EP3714275A4
(en)
|
2017-11-22 |
2021-10-27 |
Gritstone bio, Inc. |
REDUCTION OF JUNCTION EPITOPIC PRESENTATION FOR NEOANTIGENS
|
|
CN111511754B
(zh)
|
2017-12-20 |
2023-09-12 |
捷克共和国有机化学与生物化学研究所 |
活化sting转接蛋白的具有膦酸酯键的2’3’环状二核苷酸
|
|
US10966999B2
(en)
|
2017-12-20 |
2021-04-06 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3′3′ cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
|
WO2019125974A1
(en)
|
2017-12-20 |
2019-06-27 |
Merck Sharp & Dohme Corp. |
Cyclic di-nucleotide compounds as sting agonists
|
|
US12065649B2
(en)
|
2018-01-09 |
2024-08-20 |
Vanderbilt University |
Pattern recognition receptor agonist prodrugs and methods of use thereof
|
|
US12220462B1
(en)
|
2018-02-13 |
2025-02-11 |
Abionyx Pharma Sa |
Complexes for delivery of cyclic dinucleotides
|
|
WO2019161171A1
(en)
*
|
2018-02-16 |
2019-08-22 |
Sperovie Biosciences, Inc. |
Nanoparticle formulations of sting agonists
|
|
EP3768310A1
(en)
|
2018-03-23 |
2021-01-27 |
Codiak BioSciences, Inc. |
Extracellular vesicles comprising sting-agonist
|
|
JP2021519279A
(ja)
|
2018-03-27 |
2021-08-10 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
修飾環式ジヌクレオチド化合物
|
|
JP2021519270A
(ja)
|
2018-03-27 |
2021-08-10 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
２−アザ−ヒポキサンチンまたは６ｈ−ピラゾロ［１，５−ｄ］［１，２，４］トリアジン−７−オンをｓｔｉｎｇアゴニストとして含む環式ジヌクレオチド化合物
|
|
WO2019195063A1
(en)
|
2018-04-03 |
2019-10-10 |
Merck Sharp & Dohme Corp. |
Aza-benzothiophene compounds as sting agonists
|
|
WO2019195124A1
(en)
|
2018-04-03 |
2019-10-10 |
Merck Sharp & Dohme Corp. |
Benzothiophenes and related compounds as sting agonists
|
|
WO2019195658A1
(en)
|
2018-04-05 |
2019-10-10 |
Dana-Farber Cancer Institute, Inc. |
Sting levels as a biomarker for cancer immunotherapy
|
|
TWI833744B
(zh)
|
2018-04-06 |
2024-03-01 |
捷克科學院有機化學與生物化學研究所 |
3'3'-環二核苷酸
|
|
TWI818007B
(zh)
|
2018-04-06 |
2023-10-11 |
捷克科學院有機化學與生物化學研究所 |
2'3'-環二核苷酸
|
|
TW202005654A
(zh)
|
2018-04-06 |
2020-02-01 |
捷克科學院有機化學與生物化學研究所 |
２，２，─環二核苷酸
|
|
US20190359645A1
(en)
|
2018-05-03 |
2019-11-28 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3'-cyclic dinucleotides comprising carbocyclic nucleotide
|
|
GB201807924D0
(en)
|
2018-05-16 |
2018-06-27 |
Ctxt Pty Ltd |
Compounds
|
|
ES2929415T3
(es)
|
2018-05-25 |
2022-11-29 |
Incyte Corp |
Compuestos heterocíclicos tricíclicos como activadores de STING
|
|
CN112512531B
(zh)
|
2018-06-01 |
2024-04-09 |
卫材R&D管理有限公司 |
用于膀胱癌的治疗的方法
|
|
CA3106110A1
(en)
|
2018-07-10 |
2020-01-16 |
Sperovie Biosciences, Inc. |
Compounds, compositions, and methods for the treatment of disease
|
|
WO2020028565A1
(en)
|
2018-07-31 |
2020-02-06 |
Incyte Corporation |
Tricyclic heteraryl compounds as sting activators
|
|
WO2020028566A1
(en)
|
2018-07-31 |
2020-02-06 |
Incyte Corporation |
Heteroaryl amide compounds as sting activators
|
|
CA3107263A1
(en)
*
|
2018-08-03 |
2020-02-06 |
The University Of Tokyo |
Nasal vaccine that induces cell-mediated immunity
|
|
MX2020013322A
(es)
|
2018-08-16 |
2021-02-22 |
Eisai R&D Man Co Ltd |
Sales de compuestos y cristales de los mismos.
|
|
KR102567590B1
(ko)
|
2018-09-06 |
2023-08-17 |
다이이찌 산쿄 가부시키가이샤 |
신규 고리형 디뉴클레오티드 유도체 및 그 항체 약물 콘쥬게이트
|
|
US20220031825A1
(en)
*
|
2018-09-17 |
2022-02-03 |
Quratis Inc. |
Immunological adjuvant and vaccine composition including sting agonist
|
|
KR102755652B1
(ko)
|
2018-09-21 |
2025-01-21 |
상하이 드 노보 파마테크 컴퍼니 리미티드 |
고리형 디뉴클레오티드 유사체, 이의 약학 조성물 및 용도
|
|
US11110106B2
(en)
|
2018-10-29 |
2021-09-07 |
Venenum Biodesign, LLC |
Sting agonists for treating bladder cancer and solid tumors
|
|
AU2019371206A1
(en)
|
2018-10-29 |
2021-05-27 |
Venenum Biodesign, LLC |
Novel sting agonists
|
|
US20220008346A1
(en)
|
2018-10-30 |
2022-01-13 |
Vanderbilt University |
Graft copolymers, methods of forming graft copolymers, and methods of use thereof
|
|
JP2022509929A
(ja)
|
2018-10-31 |
2022-01-25 |
ノバルティス アーゲー |
Ｓｔｉｎｇアゴニストを含むｄｃ－ｓｉｇｎ抗体コンジュゲート
|
|
US11596692B1
(en)
|
2018-11-21 |
2023-03-07 |
Incyte Corporation |
PD-L1/STING conjugates and methods of use
|
|
WO2020146237A1
(en)
|
2019-01-07 |
2020-07-16 |
Incyte Corporation |
Heteroaryl amide compounds as sting activators
|
|
CN111423483B
(zh)
*
|
2019-01-10 |
2025-01-17 |
英诺生物制药(深圳)有限公司 |
环二核苷酸前药分子及其制备方法和应用
|
|
DK3934757T3
(da)
|
2019-03-07 |
2023-04-17 |
Inst Of Organic Chemistry And Biochemistry Ascr V V I |
2'3'-cykliske dinukleotider og prodrugs deraf
|
|
AU2020231115B2
(en)
|
2019-03-07 |
2025-02-20 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3'-cyclic dinucleotides and prodrugs thereof
|
|
US11766447B2
(en)
|
2019-03-07 |
2023-09-26 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3′3′-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator
|
|
SG11202109702QA
(en)
|
2019-03-21 |
2021-10-28 |
Codiak Biosciences Inc |
Extracellular vesicles for vaccine delivery
|
|
US20240108747A1
(en)
|
2019-03-21 |
2024-04-04 |
Lonza Sales Ag |
Extracellular vesicle conjugates and uses thereof
|
|
US12233356B2
(en)
|
2019-03-21 |
2025-02-25 |
Lonza Sales Ag |
Process for preparing extracellular vesicles
|
|
EP3946324B1
(en)
|
2019-04-04 |
2025-07-30 |
Merck Sharp & Dohme LLC |
Inhibitors of histone deacetylase-3 useful for the treatment of cancer, inflammation, neurodegeneration diseases and diabetes
|
|
TW202104214A
(zh)
|
2019-04-05 |
2021-02-01 |
英商葛蘭素史密斯克藍智慧財產發展有限公司 |
化合物
|
|
MA55805A
(fr)
|
2019-05-03 |
2022-03-09 |
Flagship Pioneering Innovations V Inc |
Métodes de modulation de l'activité immunitaire
|
|
JP7621974B2
(ja)
|
2019-05-09 |
2025-01-27 |
アリゴス セラピューティクス インコーポレイテッド |
Ｓｔｉｎｇモジュレータとしての修飾環状ジヌクレオシド化合物
|
|
IL287938B2
(en)
|
2019-05-10 |
2025-07-01 |
Takeda Pharmaceuticals Co |
Antibody-drug conjugates
|
|
WO2021003445A1
(en)
|
2019-07-03 |
2021-01-07 |
Codiak Biosciences, Inc. |
Extracellular vesicles targeting t cells and uses thereof
|
|
US20230181758A1
(en)
|
2019-07-03 |
2023-06-15 |
Codiak Biosciences, Inc. |
Extracellular vesicles targeting dendritic cells and uses thereof
|
|
GB201910305D0
(en)
|
2019-07-18 |
2019-09-04 |
Ctxt Pty Ltd |
Compounds
|
|
GB201910304D0
(en)
|
2019-07-18 |
2019-09-04 |
Ctxt Pty Ltd |
Compounds
|
|
KR20220056176A
(ko)
|
2019-08-02 |
2022-05-04 |
메르사나 테라퓨틱스, 인코포레이티드 |
암 치료를 위한 sting(인터페론 유전자의 자극인자) 작용제로서의 비스-[n-((5-카바모일)-1h-벤조[d]이미다졸-2-일)-피라졸-5-카복사미드] 유도체 및 관련 화합물
|
|
CN114127121B
(zh)
|
2019-08-12 |
2025-04-11 |
北京恩瑞尼生物科技股份有限公司 |
用于通过cd39表达细胞的adcc靶向促进和增强t细胞介导的免疫反应的方法和组合物
|
|
WO2021041532A1
(en)
|
2019-08-26 |
2021-03-04 |
Dana-Farber Cancer Institute, Inc. |
Use of heparin to promote type 1 interferon signaling
|
|
EP3785719A1
(en)
*
|
2019-08-28 |
2021-03-03 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
New use of cyclic dinucleotides
|
|
EP4034081A1
(en)
|
2019-09-25 |
2022-08-03 |
Codiak BioSciences, Inc. |
Extracellular vesicle compositions
|
|
US20230241089A1
(en)
|
2019-09-25 |
2023-08-03 |
Codiak Biosciences, Inc. |
Sting agonist comprising exosomes for treating neuroimmunological disorders
|
|
WO2021062290A1
(en)
|
2019-09-25 |
2021-04-01 |
Codiak Biosciences, Inc. |
Methods of producing extracellular vesicles
|
|
JP2022551420A
(ja)
|
2019-09-25 |
2022-12-09 |
コディアック バイオサイエンシーズ， インコーポレイテッド |
腫瘍を治療するためのｉｌ－１２提示エクソソームとｓｔｉｎｇアゴニスト含有エクソソームとの併用
|
|
TW202128775A
(zh)
|
2019-10-16 |
2021-08-01 |
英商阿法克塔生命科學有限公司 |
PD-L1抑制劑-TGFβ抑制劑雙特異性藥物部分
|
|
EP4069683A1
(en)
|
2019-12-06 |
2022-10-12 |
Mersana Therapeutics, Inc. |
Dimeric compounds as sting agonists
|
|
CN114981265B
(zh)
|
2019-12-18 |
2025-01-03 |
Ctxt私人有限公司 |
化合物
|
|
US12251449B2
(en)
|
2019-12-19 |
2025-03-18 |
William Marsh Rice University |
Synthetic multidomain peptide biomaterials that inhibit inducible nitric oxide synthase
|
|
AU2020407871A1
(en)
|
2019-12-20 |
2022-06-30 |
Nammi Therapeutics, Inc. |
Formulated and/or co-formulated liposome compositions containing toll-like receptor ("TLR") agonist prodrugs useful in the treatment of cancer and methods thereof
|
|
US11179473B2
(en)
|
2020-02-21 |
2021-11-23 |
Silverback Therapeutics, Inc. |
Nectin-4 antibody conjugates and uses thereof
|
|
US11920136B2
(en)
|
2020-02-28 |
2024-03-05 |
Tallac Therapeutics, Inc. |
Transglutaminase-mediated conjugation
|
|
BR112022015283A2
(pt)
|
2020-03-06 |
2022-09-20 |
Daiichi Sankyo Co Ltd |
Conjugado anticorpo-fármaco incluindo derivados de dinucleotídeos cíclicos
|
|
EP4117717A1
(en)
|
2020-03-13 |
2023-01-18 |
Codiak BioSciences, Inc. |
Extracellular vesicles for treating neurological disorders
|
|
EP4121450A2
(en)
|
2020-03-20 |
2023-01-25 |
Codiak BioSciences, Inc. |
Extracellular vesicles for therapy
|
|
MY210304A
(en)
|
2020-04-02 |
2025-09-10 |
Mersana Therapeutics Inc |
Antibody drug conjugates comprising sting agonists
|
|
TW202200136A
(zh)
|
2020-04-10 |
2022-01-01 |
日商小野藥品工業股份有限公司 |
癌治療方法
|
|
US20230149560A1
(en)
|
2020-04-20 |
2023-05-18 |
Massachusetts Institute Of Technology |
Lipid compositions for delivery of sting agonist compounds and uses thereof
|
|
US20210340524A1
(en)
|
2020-05-01 |
2021-11-04 |
Massachusetts Institute Of Technology |
Methods for identifying chimeric antigen receptor-targeting ligands and uses thereof
|
|
US12433954B2
(en)
|
2020-05-01 |
2025-10-07 |
Massachusetts Institute Of Technology |
Methods of activating anti-CD19 chimeric antigen receptor (CAR) T cells using amphiphilic ligand conjugates comprising CAR-targeting protein sequence motifs
|
|
CN115835856A
(zh)
|
2020-05-13 |
2023-03-21 |
麻省理工学院 |
聚合物微装置的组合物以及其在癌症免疫疗法中的用途
|
|
WO2021237100A1
(en)
|
2020-05-21 |
2021-11-25 |
Codiak Biosciences, Inc. |
Methods of targeting extracellular vesicles to lung
|
|
CN116209678A
(zh)
|
2020-07-01 |
2023-06-02 |
安尔士制药公司 |
抗asgr1抗体缀合物及其用途
|
|
KR20230061360A
(ko)
|
2020-09-02 |
2023-05-08 |
다이이찌 산쿄 가부시키가이샤 |
신규 엔도-β-N-아세틸글루코사미니다아제
|
|
WO2022066934A2
(en)
|
2020-09-23 |
2022-03-31 |
Codiak Biosciences, Inc. |
Process for preparing extracellular vesicles
|
|
WO2022066883A1
(en)
|
2020-09-23 |
2022-03-31 |
Codiak Biosciences, Inc. |
Extracellular vesicles comprising kras antigens and uses thereof
|
|
WO2022066928A2
(en)
|
2020-09-23 |
2022-03-31 |
Codiak Biosciences, Inc. |
Process for preparing extracellular vesicles
|
|
EP4216993A2
(en)
|
2020-09-23 |
2023-08-02 |
Codiak BioSciences, Inc. |
Methods of producing extracellular vesicles
|
|
WO2022079175A1
(en)
|
2020-10-14 |
2022-04-21 |
Boehringer Ingelheim International Gmbh |
Combination of a sting agonist and a complex comprising a cell penetrating peptide, a cargo and a tlr peptide agonist
|
|
AU2021363267A1
(en)
*
|
2020-10-20 |
2023-06-22 |
Tyligand Bioscience (Shanghai) Limited |
Multifunctional cyclic dinucleotide and use thereof
|
|
EP4240488A1
(en)
|
2020-11-09 |
2023-09-13 |
Takeda Pharmaceutical Company Limited |
Antibody drug conjugates
|
|
JP2023554396A
(ja)
|
2020-12-17 |
2023-12-27 |
トラスティーズ オブ タフツ カレッジ |
Ｆａｐ活性化ラジオセラノスティクスおよび関連する使用
|
|
EP4032545A1
(en)
*
|
2021-01-26 |
2022-07-27 |
Medizinische Hochschule Hannover |
Immunogenic composition and vaccine containing chlamydia ssp. surface antigens and its use
|
|
JP2024514707A
(ja)
|
2021-04-20 |
2024-04-02 |
アンスティテュ・クリー |
免疫療法における使用のための組成物及び方法
|
|
WO2022223622A1
(en)
|
2021-04-20 |
2022-10-27 |
Institut Curie |
Compositions and methods for use in immunotherapy
|
|
WO2022234003A1
(en)
|
2021-05-07 |
2022-11-10 |
Avacta Life Sciences Limited |
Cd33 binding polypeptides with stefin a protein
|
|
WO2023056468A1
(en)
|
2021-09-30 |
2023-04-06 |
Codiak Biosciences, Inc. |
Extracellular vesicle comprising cholesterol tagged sting-agonist
|
|
EP4413038A1
(en)
|
2021-10-07 |
2024-08-14 |
Avacta Life Sciences Limited |
Pd-l1 binding affimers
|
|
TW202346322A
(zh)
|
2022-03-02 |
2023-12-01 |
日商第一三共股份有限公司 |
含Ｆｃ分子之製造方法
|
|
US20230414763A1
(en)
|
2022-03-04 |
2023-12-28 |
Massachusetts Institute Of Technology |
Transmucosal amphiphile-protein conjugate vaccine
|
|
WO2023218243A1
(en)
|
2022-05-12 |
2023-11-16 |
Avacta Life Sciences Limited |
Lag-3/pd-l1 binding fusion proteins
|
|
EP4569129A1
(en)
*
|
2022-08-10 |
2025-06-18 |
Aldevron, LLC |
Methods for producing cyclic dinucleotides
|
|
EP4582106A1
(en)
|
2022-08-29 |
2025-07-09 |
Daiichi Sankyo Company, Limited |
Antibody-drug conjugate including mutant fc region
|
|
CN115381936A
(zh)
*
|
2022-08-29 |
2022-11-25 |
福建师范大学 |
一种猴痘病毒疫苗
|
|
WO2024199359A1
(zh)
*
|
2023-03-28 |
2024-10-03 |
江苏瑞科生物技术股份有限公司 |
包含环二核苷酸分子的脂质体佐剂系统及其制备方法
|
|
WO2024211577A1
(en)
|
2023-04-05 |
2024-10-10 |
Massachusetts Institute Of Technology |
Hybrid polymeric systems and methods of use thereof
|
|
CN116392585A
(zh)
*
|
2023-04-06 |
2023-07-07 |
中山大学孙逸仙纪念医院 |
一种肿瘤疫苗佐剂及其应用
|